Medical devices placed on the Hong Kong market must continue to meet safety, performance, and quality requirements even after registration and commercialization. This is where Post-Market Surveillance (PMS) becomes essential.
Under Hong Kong’s Medical Device Administrative Control System (MDACS), manufacturers, importers, and Local Responsible Persons (LRPs) are expected to monitor device performance, report adverse events, manage recalls, and maintain ongoing compliance throughout the product lifecycle.
For global manufacturers planning to expand into Hong Kong, understanding post-market surveillance requirements is critical to avoiding regulatory risks and protecting patient safety.
At OMC Medical, we help medical device companies establish effective PMS systems aligned with Hong Kong regulatory expectations and international standards.
What is Post-Market Surveillance (PMS)?
Post-Market Surveillance refers to the continuous monitoring of medical devices after they are placed on the market. The purpose of PMS is to:
Ensure continued device safety and effectiveness
Detect adverse events and product defects
Monitor product complaints and field issues
Identify corrective and preventive actions (CAPA)
Maintain compliance with Hong Kong medical device regulations
Hong Kong’s MDACS framework encourages manufacturers to implement robust PMS procedures aligned with international best practices such as ISO 13485 and global vigilance systems.
Why PMS is Important in Hong Kong
Medical devices may encounter real-world issues that are not identified during testing or clinical evaluation. Effective PMS helps manufacturers:
Reduce patient safety risks
Detect recurring product problems early
Prevent regulatory non-compliance
Support product recalls or field safety corrective actions
Maintain market reputation and customer trust
Failure to implement proper post-market monitoring can lead to:
Product withdrawal
Suspension of registration
Regulatory investigations
Increased legal and commercial risks
Key Post-Market Surveillance Requirements in Hong Kong
1. Complaint Handling System
Manufacturers must establish a documented complaint handling process to:
Receive and evaluate customer complaints
Investigate product-related incidents
Identify trends or recurring defects
Implement corrective actions
Complaint records should be maintained and made available during regulatory inspections or audits.
2. Adverse Event Reporting
Any serious adverse event associated with a medical device should be reported promptly.
Examples include:
Device malfunction leading to patient injury
Serious deterioration in health
Death associated with device usage
Incorrect labeling causing safety concerns
Manufacturers and LRPs should maintain vigilance reporting procedures to ensure timely communication with Hong Kong authorities.
3. Field Safety Corrective Actions (FSCA)
If a device presents safety concerns, corrective actions may be required, including:
Product recalls
Safety notices
Software updates
Labeling corrections
Device replacement programs
Manufacturers must maintain procedures for executing and documenting FSCAs efficiently.
4. Product Recall Procedures
Companies marketing devices in Hong Kong should maintain a formal recall management system.
A recall procedure should include:
Recall classification and risk assessment
Customer notification processes
Traceability systems
Retrieval and disposal procedures
Regulatory communication plans
Fast and transparent recalls help minimize patient risk and demonstrate regulatory responsibility.
5. Trend Reporting and Data Analysis
Manufacturers should continuously evaluate:
Complaint trends
Service reports
Failure rates
Customer feedback
Distributor observations
Trend analysis helps identify emerging risks before they become critical safety issues.
6. Periodic Review of Risk Management
Risk management activities should continue throughout the product lifecycle.
Manufacturers should:
Update risk files regularly
Reassess hazards based on market feedback
Review benefit-risk profiles
Implement preventive measures where needed
This process should align with ISO 14971 risk management principles.
7. Documentation and Record Keeping
Proper documentation is essential for PMS compliance.
Required records may include:
Complaint files
Adverse event reports
CAPA records
Recall documentation
Investigation reports
PMS plans and procedures
Distributor communications
Maintaining organized documentation helps demonstrate regulatory readiness.
Role of the Local Responsible Person (LRP)
In Hong Kong, the Local Responsible Person (LRP) plays an important role in post-market activities.
The LRP may assist with:
Complaint communication
Adverse event coordination
Recall execution
Regulatory correspondence
Market surveillance support
Choosing an experienced LRP is essential for smooth regulatory operations in Hong Kong.
How OMC Medical Supports PMS Compliance in Hong Kong
At OMC Medical, we provide end-to-end regulatory support for medical device manufacturers entering the Hong Kong market.
Our Hong Kong PMS support services include:
Post-market surveillance strategy development
Vigilance and adverse event reporting guidance
Recall and FSCA procedure preparation
Complaint handling system support
PMS documentation review
Ongoing regulatory compliance consulting
Our team helps manufacturers build practical and compliant PMS systems that align with Hong Kong and international regulatory expectations.
Best Practices for Post-Market Surveillance in Hong Kong
To maintain long-term compliance, manufacturers should:
Implement proactive complaint monitoring
Train distributors and local teams
Maintain updated technical documentation
Conduct regular PMS reviews
Monitor international safety alerts
Ensure rapid response to field issues
Maintain clear communication with LRPs
Strong PMS systems not only improve compliance but also strengthen product quality and patient confidence.
Conclusion
Post-Market Surveillance is a critical part of medical device compliance in Hong Kong. Manufacturers must continuously monitor device performance, manage complaints, report adverse events, and implement corrective actions when necessary.
A well-structured PMS system helps companies maintain regulatory compliance, improve patient safety, and protect brand reputation in the Hong Kong market.
With expert regulatory guidance from OMC Medical, manufacturers can simplify PMS implementation and ensure ongoing compliance under Hong Kong’s MDACS framework.
